Publicaciones (608) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma

    Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1879, Núm. 1

  2. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

    Cancers, Vol. 16, Núm. 4

  3. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

    Cancers, Vol. 16, Núm. 4, pp. 807

  4. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

    Cell Death Discovery, Vol. 10, Núm. 1

  5. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline

    British Journal of Pharmacology

  6. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

    Cancer Letters, Vol. 585

  7. Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

    Biomedicine and Pharmacotherapy, Vol. 174

  8. Kdm1a safeguards the topological boundaries of PRC2-repressed genes and prevents aging-related euchromatinization in neurons

    Nature Communications, Vol. 15, Núm. 1

  9. Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  10. Mechanistic insights into the antitumoral potential and in vivo antiproliferative efficacy of a silver-based core@shell nanosystem

    International Journal of Pharmaceutics, Vol. 655

  11. Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways

    International Journal of Pharmaceutics, Vol. 649

  12. Metastatic outgrowth via the two-way interplay of autophagy and metabolism

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 3

  13. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1

    Molecular Oncology, Vol. 18, Núm. 3, pp. 620-640

  14. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine

  15. The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives

    Seminars in Cancer Biology, Vol. 99, pp. 24-44

  16. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy

    European Journal of Pharmaceutical Sciences, Vol. 191, pp. 106600

  2. A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma

    European Journal of Pharmaceutical Sciences, Vol. 187, pp. 106476

  3. Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery

    European Journal of Pharmacology, Vol. 958

  4. Coiled-coil-mediated dimerization of Atg16 is required for binding to the PROPPIN Atg21

    Open Biology, Vol. 13, Núm. 11